Spruce Biosciences Inc [NASDAQ: SPRB] slipped around -0.18 points on Tuesday, while shares priced at $0.13 at the close of the session, down -58.02%.
Compared to the average trading volume of 311.56K shares, SPRB reached a trading volume of 29807227 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Spruce Biosciences Inc [SPRB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SPRB shares is $1.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SPRB stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Spruce Biosciences Inc shares, keeping their opinion on the stock as Perform, with their previous recommendation back on December 11, 2024. The new note on the price target was released on December 11, 2024, representing the official price target for Spruce Biosciences Inc stock. Previously, the target price had yet another drop from $9 to $2, while RBC Capital Mkts kept a Sector Perform rating on SPRB stock. On March 14, 2024, analysts decreased their price target for SPRB shares from 9 to 2.
The Average True Range (ATR) for Spruce Biosciences Inc is set at 0.04, with the Price to Sales ratio for SPRB stock in the period of the last 12 months amounting to 0.77. The Price to Book ratio for the last quarter was 0.11, with the Price to Cash per share for the same quarter was set at 1.45.
How has SPRB stock performed recently?
Spruce Biosciences Inc [SPRB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -52.62. With this latest performance, SPRB shares dropped by -60.05% in over the last four-week period, additionally sinking by -70.29% over the last 6 months – not to mention a drop of -82.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPRB stock in for the last two-week period is set at 19.68, with the RSI for the last a single of trading hit 17.23, and the three-weeks RSI is set at 22.11 for Spruce Biosciences Inc [SPRB]. The present Moving Average for the last 50 days of trading for this stock 0.3463, while it was recorded at 0.2655 for the last single week of trading, and 0.4418 for the last 200 days.
Spruce Biosciences Inc [SPRB]: Deeper insight into the fundamentals
Spruce Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.36 and a Current Ratio set at 5.36.
Insider trade positions for Spruce Biosciences Inc [SPRB]
There are presently around $44.04%, or 49.81%% of SPRB stock, in the hands of institutional investors. The top three institutional holders of SPRB stocks are: RIVERVEST VENTURE MANAGEMENT LLC with ownership of 2.94 million shares, which is approximately 7.1449%. CARLYLE GROUP INC., holding 2.9 million shares of the stock with an approximate value of $$1.52 million in SPRB stocks shares; and CARLYLE GROUP INC., currently with $$1.35 million in SPRB stock with ownership which is approximately 6.3488%.
